HIMS today
$20.02-$0.79 (-3.80%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minLeaning Bearish
5 minStrong Bearish
Daily trend turns up above $31.81
Key levels
Resistance$23.97
Resistance$21.53
Support$18.75
Support$15.21
Latest news & SEC filings
LegalFive more states join federal probe of Hims & Hers over privacy claims
EarningsHims & Hers reports Q3 miss, weak Q4 outlook, adds Huberman to board
LegalFTC expands lawsuit against Hims & Hers Health
LegalFive states join FTC lawsuit against Hims and Hers over privacy practices
AnalystJefferies keeps Hold rating on Hims & Hers Health, cuts price target to $24
All HIMS news →About Hims & Hers
Hims & Hers runs a direct-to-consumer telehealth and wellness platform where customers consult licensed clinicians online and can receive prescriptions when appropriate. Its offerings cover areas such as intimacy, thinning hair, hormonal balance, weight management, skin conditions, and emotional well-being, along with non-prescription items, cosmetics, supplements, and lab tests. Many products ship on a recurring subscription basis through its websites and apps. It serves customers in the United States, Canada, the United Kingdom, and several European countries.
Based on the company's 10-K filed Feb 23, 2026.
NYSE · Other
Hims & Hers Health, Inc. (HIMS)
What Is the Price Target for HIMS?
SEPT Low Target
$24.00
SEPT Mid Target
$32.00
SEPT High Target
$40.00
Analyst Consensus
$32.00
Is HIMS a Buy or Sell Right Now?
Thesis
- •Revenue growing 59.0% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for HIMS.
Start Free Trial →Is HIMS Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$24.33
31
Moat Score
NONE
4/9
Piotroski Score
3.6
Altman Z-Score
What Is Smart Money Doing with HIMS?
Insider Signal
SELLING
1 buys / 9 sells (90d)
Congress Signal
BUYING
1 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Boughton Soleil | officer | Sale | 3,462 | $96K | Oct 28, 2026 |
| Boughton Soleil | officer | Sale | 3,461 | $101K | Oct 14, 2026 |
| Okupe Oluyemi | officer | Buy | 14,000 | $70K | Sep 22, 2026 |
| Okupe Oluyemi | officer | Sale | 29,277 | $877K | Sep 22, 2026 |
| Okupe Oluyemi | officer | Sale | 12,313 | $355K | Sep 17, 2026 |
| Dudum Andrew | director officer 10% owner | Sale | 977,566 | - | Aug 27, 2026 |
| Dudum Andrew | director officer 10% owner | Sale | 463,289 | - | Aug 25, 2026 |
| Okupe Oluyemi | officer | Buy | 4,938 | $25K | Aug 19, 2026 |
| Okupe Oluyemi | officer | Sale | 4,938 | $148K | Aug 19, 2026 |
| Boughton Soleil | officer | Sale | 25,111 | $692K | Aug 19, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →HIMS Growth Story
Revenue YoY
59.0%
3yr Revenue CAGR
64.5%
EPS Growth YoY
-3.77%
FCF Growth YoY
-71.0%
Revenue Trend
STRONG
Dark Pool Trades for HIMS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for HIMS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:02:55 | $19.92 | 1,000 | $$20K | MIDPOINT |
| 15:02:30 | $19.93 | 1,080 | $$22K | SELL |
| 15:02:03 | $19.93 | 1,503 | $$30K | BUY |
| 15:01:58 | $19.92 | 2,000 | $$40K | SELL |
| 15:00:43 | $19.96 | 1,502 | $$30K | SELL |
5 dark pool trades shown · $$141K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for HIMS
PREVIEWSEPT Investing provides real-time options flow tracking for HIMS, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $21 | Nov 20 | 8 | $$200 | 4 | SWEEP |
| CALL | $25 | Jan 15 | 64 | $$90 | 1 | SWEEP |
| CALL | $25 | Jan 15 | 64 | $$90 | 1 | SWEEP |
| CALL | $25 | Jan 15 | 64 | $$180 | 2 | SWEEP |
| PUT | $20 | Nov 13 | 1 | $$2015 | 31 | SWEEP |
5 options trades shown · 80% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About HIMS
2 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for HIMS. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup — $HIMS (Hims & Hers Health, Inc.) Price: $31.59 | Zone: $24.73 — $35.85 Conviction: MEDIUM | Analyst upside: +10.7% Near resistance (62% of range) — breakout watch. Positive news (5+ vs ...
SEPT Brain on $HIMS -- Neutral HIMS breakout at $37.29. Day range $34.45-$38.23. Price in middle of zone $34.75-$38.23 — direction unclear, stop too wide. Wait for price to reach zone boundary for cl...
Join 3,500+ traders discussing HIMS in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Hims & Hers Health, Inc. (HIMS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (8 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →HIMS — frequently asked questions
What is HIMS stock price today?
Hims & Hers Health, Inc. (HIMS) is at $20.02, down 3.80% (-$0.79) at the Nov 12, 2026 close.
Why is HIMS stock moving today?
Latest HIMS news — Nov 11, 2026: Five more states join federal probe of Hims & Hers over privacy claims · Nov 11, 2026: Hims & Hers reports Q3 miss, weak Q4 outlook, adds Huberman to board
Why did HIMS stock move on Nov 9, 2026?
Hims & Hers Health (HIMS) reported third-quarter results that fell short of expectations, sending shares down 9.15% to close at $22.94 on heavy volume of 39.5 million shares. The company guided fourth-quarter sales to $875M-$895M, well below the $953.4M analyst estimate, and trimmed its FY2026 revenue outlook to $3.130B-$3.150B, with the midpoint below the $3.209B consensus.
What is the HIMS price target?
The average analyst price target for HIMS is $32.00, ranging from $24 to $40, based on 13 analysts. Latest: Jefferies maintains on Nov 10, 2026.
What do analysts rate HIMS?
Analyst ratings for HIMS: 0 Buy, 29 Hold, 0 Sell — consensus Hold.
Did HIMS beat earnings?
HIMS last reported on Nov 9, 2026: EPS -$0.14 vs $0.06 expected — a miss of 348.7%.
Does HIMS pay a dividend?
HIMS does not currently pay a dividend.
What are HIMS support and resistance levels?
Support: $18.75, $15.21, $11.64. Resistance: $21.53, $23.97, $26.33.
What are insiders doing with HIMS?
Insider activity: SELLING, 1 buys and 9 sells in the last 90 days.
What is the latest news on HIMS?
Nov 11, 2026: Five more states join federal probe of Hims & Hers over privacy claims · Nov 11, 2026: Hims & Hers reports Q3 miss, weak Q4 outlook, adds Huberman to board · Nov 11, 2026: FTC expands lawsuit against Hims & Hers Health